Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Precomp Solutions B | PCOMB | Nov 15, 2024 | 0.83 | -6.70 |
Premium Snacks Nordic | SNX | Nov 15, 2024 | 18.80 | 0.00 |
Preservia Holding PREF | PHOLPREF | Nov 15, 2024 | 11.80 | 0.00 |
Preservia Hyresfastigheter B | PHYRB | Nov 15, 2024 | 0.09 | +9.64 |
Preservia Hyresfastigheter PREF | PHYRPREF | Nov 15, 2024 | 38.00 | 0.00 |
Preservium Property | PRESRV | Nov 15, 2024 | 56.50 | +1.80 |
Prevas B | PREVB | Nov 15, 2024 | 101.80 | -0.97 |
Pricer B | PRICB | Nov 15, 2024 | 11.24 | -2.26 |
Prisma Properties AB | PRISMA | Nov 15, 2024 | 23.28 | -1.71 |
Proact IT Group | PACT | Nov 15, 2024 | 131.20 | -1.94 |
Probi | PROB | Nov 15, 2024 | 262.00 | +3.97 |
ProfilGruppen B | PROFB | Nov 15, 2024 | 104.00 | 0.00 |
Profoto Holding | PRFO | Nov 15, 2024 | 46.60 | -0.43 |
Projektengagemang Sweden B | PENGB | Nov 15, 2024 | 9.00 | +1.35 |
Prolight Diagnostics | PRLD | Nov 15, 2024 | 0.15 | -2.55 |
Promimic AB | PRO | Nov 15, 2024 | 35.70 | +2.88 |
ProstaLund | PLUN | Nov 15, 2024 | 0.24 | +1.67 |
Prostatype Genomics | PROGEN | Nov 15, 2024 | 8.50 | 0.00 |
Provide IT | PROVIT | Nov 15, 2024 | 1.43 | 0.00 |
Purefun | PURE | Nov 15, 2024 | 10.20 | -0.97 |
Q-Linea | QLINEA | Nov 15, 2024 | 1.19 | +4.39 |
QBank | QBNK | Nov 15, 2024 | 6.10 | 0.00 |
Qbrick | QBRICK | Nov 15, 2024 | 0.17 | +0.58 |
Qiiwi Games | QIIWI | Nov 15, 2024 | 2.88 | 0.00 |
QleanAir | QAIR | Nov 15, 2024 | 19.00 | +3.54 |
Qlife Holding | QLIFE | Nov 15, 2024 | 2.40 | 0.00 |
Qliro | QLIRO | Nov 15, 2024 | 25.80 | 0.00 |
Qlosr Group B | QLOSRB | Nov 15, 2024 | 0.14 | +6.72 |
Qlucore | QCORE | Nov 15, 2024 | 5.50 | 0.00 |
QuiaPEG Pharmaceuticals Holding AB | QUIA | Nov 15, 2024 | 0.03 | +0.59 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.